Available now: Open-access interviews with experts on the COVID-19 pandemic: epidemiology, virus biology and possible vaccines and treatmentsView All
Dr. Paul Jennings Medical University of Innsbruck, Austria2 Talks
Dr. Paul Jennings is an Assistant Professor at the Division of Physiology, Medical University of Innsbruck, Austria. He completed his PhD in 2001 in the field of in vitro nephrotoxicity at University College Dublin, Ireland and his habitation in 2009 at the Medical University of Innsbruck entitled “Epithelial Cell Cultures... read moreas tools to study human disease and the adverse effects of pharmaceuticals and chemicals.” His research is focused to understanding the molecular mechanisms of chemical induced nephrotoxicity with a strong focus on stress response pathways including but not limited to Nrf2, unfolded protein response and p53. Current models employed in his laboratory include primary human proximal tubule (PT) cells, telomerase immortalised human PT cells (RPTEC/TERT1) and human induced pluripotent stem cell derived PT and podocyte cells. His laboratory is experienced in integrated omic analysis and biokinetics. Dr. Jennings’ research group is an integral member of several key European Projects which aim to improve drug safety assessment regimes and to further understand renal disease processes.